Temple Rock Holdings Inc.

CYNAPSUS ANNOUNCES DEBENTURE FINANCING
TORONTO, ONTARIO--(Marketwire - Jan. 28, 2011) - Cynapsus Therapeutics Inc. ("Cynapsus" or the "Corporation") (formerly Cannasat Therapeutics Inc.) (TSX VENTURE:CTH) announced today that it has arranged financing (the "Financing") of secured Series C Debentures ("Secured Debentures") in the aggregate principal amount of $300,000. MORE>>